3-1 Acne Treatment Pads

Description

CVS Health™ 3-in-1 Acne Treatment Pads contain 2% Salicylic Acid as the active ingredient. These pads are indicated for the treatment of acne pimples and blackheads. The mechanism of action involves penetrating the pores to clear most acne blemishes, aiding in skin clarity and helping to prevent future breakouts. Each pad measures 2.25 inches (5.7 cm) in diameter, and the product is packaged with a total of 90 pads.

Uses and Indications

This drug is indicated for the treatment and prevention of acne. It effectively helps clear up acne pimples and blackheads by penetrating the pores to eliminate most acne blemishes. Additionally, it aids in improving overall skin clarity and helps prevent future breakouts.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. This can be done one to three times daily, depending on the patient's needs and the physician's guidance.

It is advisable to initiate treatment with one application per day to minimize the risk of excessive drying of the skin. Based on the patient's response, the frequency may be gradually increased to two or three times daily as necessary or as directed by a healthcare provider.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once daily or every other day to alleviate these side effects.

Contraindications

This product is contraindicated in individuals with a known allergy to salicylic acid or aspirin. Due to the potential for irritation, it is advised to use only one topical acne medication at a time. Additionally, contact with the eyes, lips, and mouth should be avoided; in the event of contact with the eyes, they should be rinsed thoroughly with water.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from extreme heat or open flame.

When utilizing this product, it is imperative to avoid contact with the eyes, lips, and mouth. In the event of accidental contact with the eyes, it is essential to rinse the eyes thoroughly with water. Individuals with a known allergy to salicylic acid or aspirin should refrain from using this product. Additionally, the likelihood of skin irritation and dryness increases if another topical acne medication is used concurrently. To minimize the risk of irritation, it is recommended to use only one topical acne medication at a time.

In case of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised. No specific laboratory tests are required for monitoring during the use of this product.

Side Effects

Patients should be aware that the product is intended for external use only and is flammable; it should be kept away from extreme heat or open flame.

In clinical use, patients with a known allergy to salicylic acid or aspirin should not use this product. Additionally, the concurrent use of another topical acne medication may increase the likelihood of skin irritation and dryness. If irritation occurs, it is advised that patients limit their use to one topical acne medication at a time to mitigate these effects.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of 3-1 Acne Treatment Pads (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily. Depending on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily. Care should be taken to observe for excessive drying of the skin; if bothersome dryness or peeling occurs, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of 3-1 Acne Treatment Pads (salicylic acid swab) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Further studies may be necessary to establish the safety profile of this treatment in pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, it is imperative that immediate medical assistance is sought. Healthcare professionals should advise patients or caregivers to contact a Poison Control Center without delay if the substance has been ingested.

Symptoms of overdosage may vary depending on the specific substance involved; however, prompt recognition and intervention are crucial. The management of overdosage typically involves supportive care and symptomatic treatment, tailored to the individual patient's needs.

Healthcare providers are encouraged to monitor the patient closely for any adverse effects and to initiate appropriate therapeutic measures as necessary.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use this product if they have a known allergy to salicylic acid or aspirin. It is important for healthcare providers to discuss the potential for skin irritation and dryness, which may be exacerbated if patients use another topical acne medication concurrently. If irritation occurs, patients should be advised to limit their use to one topical acne medication at a time.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes, lips, and mouth while using this product. In the event of accidental contact with the eyes, patients should be instructed to rinse their eyes thoroughly with water.

Storage and Handling

This product is classified as flammable and must be kept away from extreme heat or open flame. It should be stored in a cool, dry place to maintain its integrity. Additionally, it is essential to keep this product out of reach of children. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the product is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for 3-1 Acne Treatment Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)